๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of substituted benzamides as P2 ligands for symmetry-based inhibitors of HIV protease

โœ Scribed by Dale J. Kempf; Charles A. Flentge; Norman E. Wideburg; Ayda Saldivar; Sudthida Vasavanonda; Daniel W. Norbeck

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
225 KB
Volume
5
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evaluation of furofuran as a P2 ligand f
Evaluation of furofuran as a P2 ligand for symmetry-based HIV protease inhibitors
โœ Xiaoqi Chen; Lin Li; Dale J. Kempf; Hing Sham; Norman E. Wideburg; Ayda Saldivar ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 313 KB

The hexahydrofurofuranyloxy group was evaluated as a conformationally constrained P2 ligand for symmetry-based HIV protease inhibitors. A number of compounds showed nM level activity against HIV in MT4 cells and lower protein binding than the licensed protease inhibitor ritonavir. However, replaceme

Structure-based design of achiral, nonpe
Structure-based design of achiral, nonpeptidic hydroxybenzamide as a novel P2/P2โ€ฒ replacement for the symmetry-based HIV protease inhibitors
โœ Ramnarayan S. Randad; Lucyna Lubkowska; Abelardo M. Silva; Diego M.A. Guerin; Se ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 737 KB

A combination of structure-activity studies, kinetic analysis, X-ray crystallographic analysis, and modeling were employed in the design of a novel series of HIV-1 protease (HIV PR) inhibitors. The crystal structure of a complex of HIV PR with SRSS-2,5-bis[N-(tert-butyloxycarbonyl)amino]-3,4-dihydro